An interview with Andrew Schwartz, Group Managing Director and Chief Investment Officer of Qualitas.
Copyright 2020 – Finance News Network
Source: Finance News Network
10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
Read More09 Jan 2020 - IVE Group Limited (ASX:IGL) Executive Chairman, Geoff Selig, discusses the company's recent acquisition of Salmat Marketing Solutions and Reach Media New Zealand and its recent move to trading under the one IVE brand.
Read More27 Nov 2020 - East 33 Limited (ASX:E33) Co-founder and Executive Chairman James Garton talks about the company's dominant position as a supplier and distributor of Sydney Rock Oysters, ambitions ahead of its listing on the ASX and the potential of the world-class Sydney Rock Oyster as a luxury food alongside French Champagne or Beluga Caviar.
Read More18 Jul 2023 - Dr Shane Oliver, Chief Economist at AMP, discusses the impact of interest rates and alternatives for fighting inflation.
Read More31 Oct 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the market outlook, giving general advice on investment implications.
Read More10 Nov 2023 - Joe Hayes, Managing Director of Wexted Advisors, discusses Safe Harbour strategies, guiding companies to conquer financial challenges with confidence.
Read More23 Sep 2024 - Rob Hattersley, Group Head of Capital at MaxCap Group, provides an overview of the company, discussing the funding gap in the Australian credit market, managing risk, the tailwinds for commercial real estate debt, and opportunities within the residential and logistics property markets.
Read More20 Nov 2019 - Ausbil Investment Management Chief Investment Officer, Paul Xiradis and Ausbil Head of ESG Research, Måns Carlsson-Sweeny, provide an update on the Ausbil Active Sustainable Equity fund’s performance, talk about what the fund looks for in businesses that fit the description of "sustainable", and discuss how these characteristics provide long-term above-market returns.
Read More15 Jul 2020 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director James Graham provides an update on positive data against a range of persistent bacteria using the company's synthetic antibiotic RECCE 327, commencement of Phase I human clinical trial in 2H20 and key priorities.
Read More24 Jul 2023 - Magnis Energy Technologies Limited (ASX:MNS) Managing Director (US) Hoshi Daruwalla and Technical Advisory Committee members Dr Michael Osborne and Wade Guindy discuss progress, focusing on the company's lithium-ion battery manufacturing plant, iM3NY.
Read More
